MPR
@eMPR
MPR provides daily drug news and industry-supported drug information & education. Download our drug reference and clinical tools app today!
You might like
Breakthrough Therapy designation granted to ianalumab to treat for Sjögren disease. empr.com/news/fda-grant…
📢 Latest MPR Pod out now! We sat down with US News and World Report's Annika Urban to discuss the top health trends for 2026. Listen now! empr.com/news/mpr-weekl…
The court said the cuts may have been retaliation for the group speaking out against the federal government. empr.com/news/judge-ord…
In 2025 the FDA approved a wide range of therapies, view them all on MPR, listed by therapeutic category. empr.com/news/2025-fda-…
Manufacturers to remove suicidal ideation warnings from Saxenda, Wegovy, and Zepbound labels following a large-scale FDA safety investigation. empr.com/news/fda-finds…
Law feature: A jury initially awarded damages for unwanted resuscitation but the defense prevailed on appeal. empr.com/features/unwan…
Study suggests GLP-1 use may optimize psoriatic arthritis outcomes. empr.com/news/tirzepati…
empr.com
Tirzepatide Added to Ixekizumab Improves Outcomes in Patients With PsA
The phase 3b TOGETHER-PsA trial evaluated the safety and efficacy of concomitant ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.
An analysis of 70,000 children with a follow-up period of 6 to 8 years, assessed whether assisted reproductive technology has a higher risk for developing atopic dermatitis. empr.com/news/assisted-…
The FDA has expanded the approval of Cablivi to include the treatment of certain pediatric patients. empr.com/news/cablivi-a…
FDA grant Breakthrough designation to narcolepsy treatment that has shown promise in a phase 1 trial. empr.com/news/alixorext…
At least 7.5 million people had been sickened by late December, resulting in at least 81,000 hospitalizations and 3100 deaths. empr.com/news/holiday-f…
The CDC reduces number of vaccines recommended for children; The AAP has condemned the action. empr.com/news/new-cdc-g…
The first GLP-1 pill for weight loss is now available. empr.com/news/once-dail…
Treatment approved for anemia in adults with alpha- or beta-thalassemia; expected to be available in January 2026. empr.com/news/aqvesme-a…
Andexxa will be removed from the US market after a risk for thromboembolic complication was highlighted. empr.com/news/anticoagu…
A treatment for hypoactive sexual desire disorder has been expanded to include postmenopausal women. empr.com/news/addyi-ind…
The rules could impact federal funding for hospitals providing these services to minors. #HHS #HealthcarePolicy #MPR #MedicalNews Read the breakdown ➡️ empr.com/news/hhs-moves…
📢 New MPR Podcast out now! 🗳️ ACIP vote 8-3 to change the Hep B vax recommendation for infants born to HBsAg-negative mothers, prompting a strong response from the AAP. ➡️ Plus, retatrutide phase 3 data shows significant weight loss, and more! ➡️ empr.com/news/mpr-weekl…
A once-weekly triple hormone receptor agonist has promising results in treating obesity/overweight and knee ostheoarthritis. empr.com/news/triumph-4…
United States Trends
- 1. Carrick N/A
- 2. Amorim N/A
- 3. MANCHESTER IS RED N/A
- 4. #MUNMCI N/A
- 5. #MUFC N/A
- 6. Donnarumma N/A
- 7. Good Saturday N/A
- 8. #GGMU N/A
- 9. Tosin N/A
- 10. Haaland N/A
- 11. #ManUtd N/A
- 12. Dalot N/A
- 13. #MeAndTheeSeriesFinalEP N/A
- 14. Dorgu N/A
- 15. Man City N/A
- 16. Jayda N/A
- 17. Casemiro N/A
- 18. Maguire N/A
- 19. Foden N/A
- 20. GAME DAY N/A
You might like
-
MACRO
@stayMACRO -
Icahn School of Medicine at Mount Sinai
@IcahnMountSinai -
Susan
@emma6USA -
JuliaAPRN
@JuliaNPAdvocate -
John Mandrola, MD
@drjohnm -
MCW VIR
@MCW_VIR -
Shikha Jain MD, FACP
@ShikhaJainMD -
Rick Pearson
@rap30 -
Minnesota Farm Bureau
@MNFarmBureau -
@KyowaKirin_US
@KyowaKirin_US -
HCPLive
@HCPLiveNews -
Gary Schwitzer
@garyschwitzer -
ACUITY24
@_ACUITY24 -
Robert T Hasty, DO, FACOI, FACP
@roberthasty -
Laurenn
@laurenncarterr
Something went wrong.
Something went wrong.